help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 20, 2006
Endocrinology, doi:10.1210/en.2005-1513
A more recent version of this article appeared on July 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/7/3606    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, A.
Right arrow Articles by Saltiel, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, A.
Right arrow Articles by Saltiel, A. R.

Submitted on November 30, 2005
Accepted on April 11, 2006

Regulation of the mouse PTG promoter by the FoxA2 forkhead protein and by cAMP in H4IIE hepatoma cells

Alan Cheng, Mei Zhang, Sean M. Crosson, Zhao Q. Bao, and Alan R. Saltiel*

Departments of Internal Medicine and Physiology, Life Sciences Institute, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA

* To whom correspondence should be addressed. E-mail: saltiel{at}lsi.umich.edu.

The scaffolding protein PTG (Protein Targeting to Glycogen) orchestrates the signaling of several metabolic enzymes involved in glycogen synthesis. However, little is known concerning the regulation of PTG itself. In this study, we have cloned and characterized the mouse promoter of PTG. We identified multiple FoxA2 binding sites within this region. FoxA2 is a member of the forkhead family of transcription factors that has recently been implicated in the cAMP-dependent regulation of several genes involved in liver metabolism. Using luciferase reporter constructs, we demonstrate that FoxA2 trans-activates the PTG promoter in H4IIE hepatoma cells. Nuclear extracts prepared from mouse liver and H4IIE cells were able to bind a FoxA2 specific probe derived within the PTG promoter region. Chromatin immunoprecipitation (ChIP) experiments further demonstrate that FoxA2 binds to the PTG promoter in vivo. Finally we show that treatment with cAMP analogs activates the PTG promoter and significantly increased PTG levels in H4IIE cells. Our results provide a framework to investigate how additional transcription factors may regulate PTG expression in other cell types.


Key words: PTG • FoxA2 • transcription • cAMP • glycogen • hepatocytes




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
E. D. Wederell, M. Bilenky, R. Cullum, N. Thiessen, M. Dagpinar, A. Delaney, R. Varhol, Y. Zhao, T. Zeng, B. Bernier, et al.
Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing
Nucleic Acids Res., July 8, 2008; (2008) gkn382v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society